Deals
Neuberger Berman surpasses target for private equity secondary fund
Neuberger Berman was able to surpass its original target of USD 1.6 billion for its third private equity secondary fund when it raised USD 2 billion.
Biotech company Cara Therapeutics files for IPO
Connecticut-based Cara Therapeutics Inc. announced its recent filing with the SEC about the proposed initial public offering of the biotechnology company's common stock.
Merz Pharma purchases aesthetics specialist Anteis
Merz Pharma group recently bought Geneva-based aesthetics medicine specialist Antes SA for an unconfirmed amount in a transaction that would extend its product reach to North America
JZ Capital Partners, Avenue Capital Group announces launch of new firm
JZ Capital Partners and Avenue Capital Group joined hands to form Toro Finance, a new investment vehicle that would focus on financing small and medium-sized companies based in Spain.




